Dutasteride
Top View
- Dutasteride and Finasteride for Men with Benign Prostatic Hyperplasia: Comparative Clinical Effectiveness and Safety
- Prostate Cancer Patients Can Benefit from 5-Alpha-Reductase
- Reductase Inhibitor Dutasteride on Localized Prostate Cancer Results from a 4-Month Pre-Radical Prostatectomy Study
- The AVOCAT Study
- Medical Management of Gender Transition
- For Benign Prostatic Hyperplasia STEPHEN A
- Avodart) Reference Number: ERX.NPA.26 Effective Date: 09.01.17 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log
- Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies
- Phase II Study of Androgen Synthesis Inhibition with Ketoconazole
- Dutasteride Reduces Viral Shedding, in Ammatory
- New Zealand Data Sheet 1
- In the Treatment of Patients with Prostate Cancer
- PROPECIA Safely and Effectively
- Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: the Fight Goes On
- Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People
- Hirsutism Acne and Hair Loss Management Of
- Hair Loss in Women
- AVODART 3 (Dutasteride) 4 Soft Gelatin Capsules